{"id":9654,"date":"2021-03-24T13:09:23","date_gmt":"2021-03-24T12:09:23","guid":{"rendered":"https:\/\/ggba.swiss\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/"},"modified":"2023-07-04T13:43:34","modified_gmt":"2023-07-04T11:43:34","slug":"societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/","title":{"rendered":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament"},"content":{"rendered":"<p>Le SELUTION SLR de <a href=\"https:\/\/medalliance.com\/\" target=\"_blank\" rel=\"noopener\">MedAlliance<\/a> est un nouveau ballon \u00e0 \u00e9lution de sirolimus qui permet une lib\u00e9ration contr\u00f4l\u00e9e et prolong\u00e9e d&rsquo;un m\u00e9dicament limus, avec un temps d&rsquo;\u00e9lution similaire \u00e0 celui des endoproth\u00e8ses \u00e0 \u00e9lution m\u00e9dicamenteuse (DES), sans que rien ne soit perdu.<\/p>\n<p>Se consacrant au d\u00e9veloppement de <a href=\"https:\/\/medalliance.com\/selution-slr\/\" target=\"_blank\" rel=\"noopener\">ballons \u00e0 \u00e9lution m\u00e9dicamenteuse<\/a> (DEB) innovants pour les patients souffrant de maladies coronariennes et art\u00e9rielles p\u00e9riph\u00e9riques potentiellement mortelles, la soci\u00e9t\u00e9 utilise une technologie propri\u00e9taire r\u00e9volutionnaire qui combine la s\u00e9curit\u00e9 et l&rsquo;efficacit\u00e9 prouv\u00e9es du sirolimus, un m\u00e9dicament cytostatique, avec des micror\u00e9servoirs en polym\u00e8re biod\u00e9gradable comme syst\u00e8mes d&rsquo;administration du m\u00e9dicament avec une technologie lipidique exclusive qui lie les micror\u00e9servoirs \u00e0 la surface du ballon.<\/p>\n<p>La lev\u00e9e de fonds de plus de USD 50 millions a \u00e9t\u00e9 rendue possible gr\u00e2ce au nouvel investisseur <a href=\"http:\/\/www.citiccapital.com\/SitePages\/private-equity-eng.aspx\" target=\"_blank\" rel=\"noopener\">Trustar Capital<\/a>, une filiale sp\u00e9cialis\u00e9e dans le capital-investissement de la soci\u00e9t\u00e9 chinoise CITIC Capital Holdings Limited.<\/p>\n<p>\u00ab\u00a0Nous sommes tr\u00e8s heureux d&rsquo;avoir Trustar Capital comme partenaire privil\u00e9gi\u00e9 et avons \u00e9tabli une relation solide avec leur \u00e9quipe sur une p\u00e9riode de temps importante. Leurs connaissances approfondies et leur expertise du march\u00e9 mondial des dispositifs m\u00e9dicaux nous seront extr\u00eamement utiles\u00a0\u00bb, explique Jeffrey B. Jump, Chairman et CEO de MedAlliance.<\/p>\n<p>Bas\u00e9e \u00e0 Nyon (canton de Vaud), au c\u0153ur de la \u00ab\u00a0<a href=\"https:\/\/www.republic-of-innovation.org\/HealthValley\/\" target=\"_blank\" rel=\"noopener\">Health Valley<\/a>\u00a0\u00bb, MedAlliance est la premi\u00e8re soci\u00e9t\u00e9 de ballons \u00e0 \u00e9lution m\u00e9dicamenteuse au monde \u00e0 recevoir le statut de \u00ab\u00a0Breakthrough Device Designation \u00ab de la FDA am\u00e9ricaine pour un DEB au sirolimus, qui a r\u00e9cemment re\u00e7u le statut de \u00ab Breakthrough\u00bb (soit une perc\u00e9e scientifique) pour SELUTION SLR dans le traitement des l\u00e9sions ath\u00e9roscl\u00e9rotiques dans les art\u00e8res coronaires natives.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 nyonnaise MedAlliance a lev\u00e9 plus de USD 50 millions en fonds propres pour son nouveau ballon qui permet une lib\u00e9ration contr\u00f4l\u00e9e et prolong\u00e9e d&rsquo;un m\u00e9dicament de sirolimus. Ces fonds seront utilis\u00e9s pour financer la commercialisation de SELUTION SLR et la mise en place de programmes cliniques mondiaux.<\/p>\n","protected":false},"author":3,"featured_media":9655,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1041,1060,1069],"class_list":["post-9654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr","tag-medtech-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 nyonnaise MedAlliance a lev\u00e9 plus de USD 50 millions en fonds propres pour son nouveau ballon qui permet une lib\u00e9ration contr\u00f4l\u00e9e et prolong\u00e9e d&#039;un m\u00e9dicament de sirolimus. Ces fonds seront utilis\u00e9s pour financer la commercialisation de SELUTION SLR et la mise en place de programmes cliniques mondiaux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-24T12:09:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament\",\"datePublished\":\"2021-03-24T12:09:23+00:00\",\"dateModified\":\"2023-07-04T11:43:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\"},\"wordCount\":322,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png\",\"keywords\":[\"Financing\",\"Medtech\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\",\"name\":\"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png\",\"datePublished\":\"2021-03-24T12:09:23+00:00\",\"dateModified\":\"2023-07-04T11:43:34+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/","og_locale":"fr_FR","og_type":"article","og_title":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area","og_description":"La soci\u00e9t\u00e9 nyonnaise MedAlliance a lev\u00e9 plus de USD 50 millions en fonds propres pour son nouveau ballon qui permet une lib\u00e9ration contr\u00f4l\u00e9e et prolong\u00e9e d'un m\u00e9dicament de sirolimus. Ces fonds seront utilis\u00e9s pour financer la commercialisation de SELUTION SLR et la mise en place de programmes cliniques mondiaux.","og_url":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-03-24T12:09:23+00:00","article_modified_time":"2023-07-04T11:43:34+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png","type":"image\/png"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament","datePublished":"2021-03-24T12:09:23+00:00","dateModified":"2023-07-04T11:43:34+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/"},"wordCount":322,"image":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png","keywords":["Financing","Medtech","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/","url":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/","name":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png","datePublished":"2021-03-24T12:09:23+00:00","dateModified":"2023-07-04T11:43:34+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Selution-SLR-630x380-3.png","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"La soci\u00e9t\u00e9 medtech MedAlliance l\u00e8ve plus de USD 50 millions pour commercialiser ses ballons \u00e0 \u00e9lution de m\u00e9dicament"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9654"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9654\/revisions"}],"predecessor-version":[{"id":17902,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9654\/revisions\/17902"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9655"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}